Comparative studies have shown that cultured vascular smooth muscle cells from spontaneously hypertensive rats (SHR) proliferate to a higher cell number, grow to a greater density, and have greater specific growth rate, particularly at a higher saturation density, than those of the normotensive Wistar-Kyoto (WKY) control rats. The growth difference was not due to varying cell survival nor to attachment ability after passage. The degree of DNA synthesis was estimated by [^Hlthymidine incorporation into newly synthesized DNA. and demonstrated not only in the heart but also in the kidney 4 of newborns representing several models of genetic hypertension. 5 In addition, the heart and kidney of newborn spontaneously hypertensive rats (SHR) present enhanced DNA synthesis in vivo.
pathophysiology of hypertension, therefore, has to be ascertained.
The present study was designed to explore the growth characteristics of rat aortic smooth muscle cells in culture since these cells are deprived of in vivo high blood pressure and the part of their behavior that persists in culture may better reveal genetic differences. Specifically, we examined 1) proliferation of VSMC and its relation to initial plating density as well as plating efficiency, 2) the specific growth rate of VSMC, 3) the effect of calf serum on DNA synthesis, and 4) the ability of VSMC to enter the S phase after stimulation by platelet-derived growth factor (PDGF) and epidermal growth factor (EGF).
Materials and Methods

Cell Culture
Cultured VSMC were obtained by an explant method 10 from aortas of 10-13-week-old male SHR and WKY rats, as described previously.
1112 Both strains were purchased from Charles River Canada (St. Constant, Quebec, Canada). After administration of sodium pentobarbital (0.52 mg/kg) anesthesia, segments of thoracic aortas were aseptically removed by careful dissection. Fat and connective tissue were then discarded, and the aortas were longitudinally opened, pinned onto a wax-coated petri dish with the endothelial side up, and immersed in Dulbecco's Modified Eagle's Medium (DMEM) (Gibco Labs., Burlington, Ontario, Canada) supplemented with 300 units/ml penicillin and 300 ^g/ml streptomycin (Sigma Chemical Co., St. Louis, Missouri). Endothelial cells were removed by scraping with a dull scalpel, and segments of the tunica media were teased off the tunica adventitia with fine forceps. These medial segments, which are virtually free of fibroblasts and endothelial cells, were rinsed several times with DMEM plus 300 units/ml penicillin and 300 ^g/ml streptomycin, cut into small slices (1 mm 2 ), and placed in 25-cm 2 tissue culture flasks (Gibco) with a drop of DMEM plus 100 units/ml penicillin and 100 nglm\ streptomycin plus 15% fetal calf serum (Gibco). The pieces were left for several hours to firmly attach to the bottom of the dishes. The flasks were gassed with 95% air and 5% CO 2 , loosely stoppered, and placed in a 37° C incubator. Fresh medium was gradually added during the first day until a volume of 5 ml was reached, and the dishes were then left undisturbed for at least 7 days. Smooth muscle cells grew from the explants within 10-20 days. At this point, the 15% fetal calf serum was gradually replaced by 10% calf serum (Gibco). When the cells reached confluency in 7-10 days, they exhibited a hill-and-valley pattern typical of smooth muscle cells in culture. They were then passaged by trypsinization with 0.05% trypsin (Gibco) in Ca
2+
-and Mg
-free Dulbecco's phosphate buffered saline and inoculated into 80-cm 2 tissue culture flasks at a density of 1 x 10 5 cells/ml. Under these conditions, the VSMC reacted positively to specific smooth muscle myosin antibodies, as examined by fluorescence microscopy. Morphology of VSMC was verified routinely by light microscopy.
Cell Number Determination
The VSMC were trypsinized, subsequently neutralized, and resuspended in culture medium (DMEM+10% calf serum+100 units/ml penicillin and 100 /xg/ml streptomycin). They were then plated in 35-mm Nunclon tissue culture dishes (Gibco) at specified concentrations (1.25xl0 3 -4.0xl0 5 cells/ plate). After different time intervals, they were trypsinized and counted in a Coulter counter (Coulter Elec, Inc., Hialeah, Florida).
Specific Growth Rate Determination . After trypsinization, VSMC were inoculated at varying concentrations from 4.0X10 4 cells/well in Falcon 24-well cluster dishes (Canlab, Montreal, Quebec, Canada) to lO.Ox 10 3 cells/plate (Nunclon). At defined time intervals, they were trypsinized and counted. Their specific growth rate was calculated with the formula: (P 2 -P,)/Pi(t 2 -t,), where P, and P 2 are the cell numbers at respective times t, and t 2 .
Establishment of Quiescence
The trypsinized cells were plated at a concentration of 4 x 10 4 cells/well in culture medium in 24-well cluster dishes. They were allowed to attach for 12 hours, and thereafter the culture medium was changed to DMEM supplemented with insulin (5 |ig/ml), transferrin (5 /ig/ml), and selenium (5 ng/ ml) (ITS) or with plasma-derived serum that had been passed through a Carboxymethyl-Sephadex (Pharmacia, Baie D'Urf<6, Quebec, Canada) column to remove PDGF. 13 The cells were incubated in this medium for 48-72 hours to establish quiescence.
Determination ofDNA Synthesis
As described previously," the 24-well cluster dishes containing VSMC that had been rendered quiescent were replenished with fresh DMEM plus 100 units/ml penicillin and 100 /xg/ml streptomycin, and the agents to be tested were added for 24 hours. At the end of this time period, the medium was changed to DMEM containing 0. H]thymidine, and the cells were fixed in 1 ml ethanol: acetic acid (3:1) solution for 10 minutes. The fixative was discarded, and the cells were washed with 1.0 ml H 2 O. Acid-insoluble material was precipitated by incubation with 1.5 ml cold 0.5N perchloric acid for 15 minutes. The cells were washed further with 1.0 ml cold perchloric acid, and DNA was extracted into 1.5 ml perchloric acid by heating at 80° C for 20 minutes. The perchloric acid containing solubilized DNA was transferred to vials holding 10 ml scintillation fluid (Phasecombining system, Amersham, Oakville, Ontario, Canada). The radioactivity incorporated into newly synthesized DNA was determined in a liquid scintillation spectrometer.
Statistical Analysis
The values are given as mean±SEM. The level of significance of differences between the means was evaluated by Student's / test for unpaired data, by two-way and three-way analysis of variance (ANOVA) with multiple comparisons according to the Bonferroni method and by the Wilcoxon nonparametric test as indicated.
Results
Vascular Smooth Muscle Cell Proliferation in Culture
Preliminary experiments evaluated the growth of cultured VSMC derived from normotensive and hypertensive rats by determination of cell number after different periods of time. Cells between passages 8 and 19 were used in these experiments. cells were inoculated at a density of 2X10 5 cells/ plate and their number was determined after 4 days in culture medium; the cells from SHR grew to a significantly higher number than those of the normotensive control rats, even after the 19th passage. In this case, the difference between SHR and WKY rats was 41%. After passages 8-13, the difference in the proliferation between VSMC from SHR and WKY rats was 52±15%, n=13; it did not vary statistically after the 14th-19th passages when the difference was 37±7%, n=\4. Although variable, the proliferation of cells of SHR from all passages studied was significantly higher than that of normotensive WKY rat cells when compared by using the Wilcoxon nonparametric test (p<0.Q\, n=21).
To ascertain if the increased growth indeed reflected a growth abnormality and not some other properties of cells of SHR, we tested the effect of initial plating density and plating efficiency. To evaluate the influence of initial plating density on cell proliferation, the cells were inoculated at different concentrations, and after 5 days they were trypsinized and counted. Figure 1 demonstrates that the VSMC from SHR proliferated to a higher cell number (p<0.05 and p<0.001, as compared with WKY rats by two-way ANOVA). Cells inoculated at a high density (4X10 5 5 cells/plate). In the groups of higher cell density at inoculation, we observed more significant differences between the two strains. The relative cell number, expressed in Figure 1 as the ratio of the final cell number to initial plating, decreased with the increasing number of cells plated. This occurrence indicated that cells of both origins were contact inhibited but always at higher densities in SHR. This finding suggested that VSMC from SHR are less sensitive to growth inhibition (see below). Additional experiments, different in time of counting (after 3 and 4 days) and plating number (1.25X10 Cells were used after the 11th and 12th passages; data from two independent experiments in triplicate and quadruplicate (n=7); p values were obtained by Student's t test; SGR was determined according to the formula (P 2 -P,)/P,(t2-t|), where P, and P 2 are cell density at times t, and t 2 . Cell density at inoculation was 4.0x10* cells/well.
hours after passage. The cells did not present any growth differences during the attachment period. The difference in cell number became significant (p<0.02 by Student's t test, and /?<0.002 by twoway ANOVA) only after 4 days in culture.
Specific Growth Rate Determination
To examine at which stage of growth the difference appears between the two cell strains, cells after 11th and 12th passages were inoculated at a concentration of 4.0x10* cells/well and counted after 2, 3, 4, and 5 days ( Table 2 ). The specific growth rate was calculated as described in Materials and Methods. At day 2, VSMC from both SHR and WKY rats were in a period of exponential growth, which continued through day 3, approached confluency at day 4, and reached maximum saturation density at day 5 (WKY, 4.1X10 3 cells/well; SHR, 5.7X10 3 cells/well). Through the period of exponential growth, the cells of SHR and WKY rats did not present any difference in specific growth rate. A significantly higher specific growth rate was reached by VSMC from SHR as compared with WKY rats at day 4 and continued at day 5 when the specific growth rate was computed with t( as the inoculation time (Table 2) . When the specific growth rate was computed for each 24-hour period, the significant difference between SHR and WKY rats was confined to a period between days 3 and 4 ( Table 2 ). Since this observation suggests that both cell types are inhibited with increasing density but that this inhibition occurs at a higher density in SHR, the cells were seeded at concentrations of 2.0x 10 5 ,4.0x 10 5 , and 10.0x 10 5 cells/plate to directly assess the effect of initial cell density. The highest specific growth rate was noted for both strains when cells were seeded at a low concentration. At this density, these VSMC were growing exponentially; however, there was no significant difference between SHR and WKY rats ( 
Effect of Calf Serum on Thymidine Incorporation into DNA
Synchronized WKY rat VSMC from the third passage presented a 7.8-fold increase of [ 3 H]thymidine incorporation after 24 hours of 10% calf serum stimulation whereas VSMC of SHR from the same passage showed a significantly higher (16.5-fold) rise (data not shown). Calf serum also elicited dose-dependent thymidine incorporation into DNA in cultured VSMC. Nonstimulated cells from the 1 lth passage from both SHR and WKY rats ( Figure  3A ) synthesized very little new DNA. With rising concentrations of calf serum, DNA synthesis was enhanced in cells of both hypertensive and normotensive origin but reached a plateau in the WKY rat group at a concentration of 5% calf serum, Data are expressed as mean±SEM. WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive rats.
Specific growth rate was determined according to the formula (P 2 -PiVP,(t2-t,), where P, and P 2 are cell density at times t, (day of inoculation) and t 2 (3 days after inoculation). *p<0.02, tp<0.01 as compared with WKY by Student's t test. whereas cells from SHR did not, even with 10% and 20% calf serum. Figure 3B illustrates the difference, expressed as "-fold" stimulation. Similar results were recorded with cells from the sixth passage. Maximal DNA synthesis in WKY rat cells was seen at a concentration of 5% calf serum (5.6-fold) whereas cells of SHR continued to synthesize more DNA with 10% and 20% calf serum (17.4-fold and 18.4-fold, respectively) (data not shown). This increased response appeared to be highly reproducible. After stimulation by 10% calf serum, which was the usual concentration in our culture medium, VSMC from SHR after the eighth passage incorporated significantly more [ (Table 4) .
Effect of Platelet-Derived Growth Factor and Epidermal Growth Factor on Thymidine Incorporation into DNA
To evaluate whether this increased growth response to calf serum was due to established growth factors, we tested the effects of PDGF and EGF in synchronized VSMC. The results of PDGF stimulation on [ 3 H]thymidine incorporation into newly synthesized DNA are shown in Figure 4 . VSMC from SHR were more liable to respond to PDGF and to commit themselves in the synthetic S When DNA synthesis was tested in response to EGF ( Figure 5 ), a stimulatory effect was evident at concentrations from 0.017 /xM to 0.17 (JM. The plateau reached in cells from both groups was significantly higher in SHR. However, the 50% effective concentration (ECJO) did not differ significantly, as determined by dose-response analysis 14 ; the only statistically significant difference was the maximal response (R^ax) ( Table 5) .
Finally, the simultaneous effect of PDGF and EGF on [ was tested. In these experiments, cells were stimulated by 0.006 and 0.06 /iM of PDGF and with increasing concentrations of EGF from 0.017 to 17 /xM (Figure 6 ). At all dose levels of these growth factors, VSMC from SHR showed a greater response than those from WKY rats.. The difference between cells from the two strains was most evident at 0.06 /iM of PDGF in the presence of increasing doses of EGF; [ 3 H]thymidine incorporation plateaued at 1.7 /xM EGF with both PDGF concentrations. As seen in Figure 6 and demonstrated in Table 5 , the addition of PDGF did not change the ECso but increased the R^ of EGF. 
Discussion
The proliferation of VSMC has been considered a consequence of the vascular injury induced by hypertension. However, Folkow 15 has proposed that a portion of elevated peripheral vascular resistance in hypertension results from structural alterations in the vessel wall mass. A 5% change in the average internal radius of resistance vessels can produce a 25% increase in peripheral vascular resistance. The notion that cardiovascular hyperplasia may be causally related to spontaneous hypertension is supported by studies 4 -6 demonstrating that cardiac and renal hyperplasia associated with genetic hypertension is present in newborns of four different spontaneously hypertensive models but absent in offspring of parents with renal and experimental hypertension. However, the pathophysiological role of smooth muscle cell hyperplasia in hypertension still remains controversial since there are reports of only hypertrophy 16 or increased DNA content without mitosis due to cell polyploidy. 17 Nevertheless, using a three-dimensional dissector, Mulvany 19 and even this elevation may have had pathophysiological consequences.
The investigations of Yamori et al 8 and Clegg et al, 9 as well as our own findings of enhanced proliferation of cultured VSMC from SHR, support the possibility that hyperplasia of VSMC is a genetic abnormality in hypertension since the cells are deprived of high blood pressure and continue to grow independently faster, even after 19 passages. Although our results show that VSMC from SHR proliferate faster approaching confluency and reach higher density, they have to be attached to the culture dish to proliferate, and they express an absolute requirement for growth factors quantitatively similar to cells from WKY rats. However, evaluation of the specific growth rate suggests that the inhibitory effect of contact on cell growth is abnormal in cells from SHR. During exponential growth, there appeared to be no difference between the two cell strains. At the time of decline of the specific growth rate, when the cells approach the confluence, the slope of decline is less steep in SHR and results in continuous growth at densities at which cells from WKY rats are already growth arrested.
The transition from the prereplicative G o -G, phase to the synthetic S phase of the cell cycle is a critical, regulated step of cell proliferation. At this point, normal cells require growth factors, such as competence factor PDGF 20 - 21 and progression factor EGF, 22 -23 which are components of serum. PDGF is a cationic 30-kD glycoprotein composed of two peptide chains with the /3 chain encoded by the protooncogene c-sis. 24 -26 EGF is a single chain anionic 6045-d polypeptide, whose receptor probably represents the product of the c-erb-B protooncogene. 2227 Both growth factors induce an ordered sequence of biochemical events with a rise in Ca 2+ -CaM, pH i; and tyrosine phosphorylation of specific substrates, which occur as crucial events in the pathway leading ultimately to DNA replication. Although expressed through independent signals, both PDGF and EGF regulate c-fos and c-myc messenger RNA (mRNA) levels, which may finally trigger DNA synthesis. 28 In addition to their mitogenic and other functions, both have striking effects on the control of vascular function.
-
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EGF and PDGF, under normal circumstances, act in concert with other stimulatory or inhibitory agents and growth factors, such as heparin or transforming growth factors (TGF). TGFa share sequence homology to EGF and bind also to its receptor with indistinguishable biological activities in vitro. 32 TGF/3, on the other hand, have a different primary sequence, 33 bind to a unique receptor distinct from the EGF receptor, 34 and exert both stimulatory and inhibitory effects on cell proliferation.
33
-37 They inhibit the serum or PDGFmediated proliferation of VSMC at subconfluent densities but augment the growth of VSMC at high cell density. 38 TGF/3 have been also reported to inhibit EGF induction of transin mRNA, 39 whose expression had been shown to be elevated by oncogenic transformation and stimulation of growth factors. 40 Smooth muscle cell growth can be also inhibited in vitro 41 as well as in vivo 42 by heparinlike molecules. Heparin reduces the number of EGF receptors on VSMC in a manner that closely parallels its antiproliferative effect. 43 By determining cell number, the present study demonstrated an increased proliferation of VSMC in response to calf serum and excluded simple polyploidy as the only difference in cells derived from SHR. 17 The experiments reported here suggest abnormal decline of the growth rate with approaching confluence. The growth factors and mechanisms responsible for the contact inhibition or slowing of the specific growth rate at high density are not all known. The selective role of stimulatory and inhibitory growth factors will have to be further evaluated at this growth-declining phase, which appears to be abnormally late in SHR. This abnormality of growth inhibition may be due to an imbalance between the expression of the EGF receptor or its effectiveness and to the different expression or effectiveness of TGF/3 and other growth stimulatoryinhibitory factors.
In addition, we observed that newly synthesized DNA, after stimulating quiescent smooth muscle cells by both PDGF and EGF, is significantly higher in VSMC from SHR. This suggests that cells derived from SHR are more liable to enter the synthetic S phase after mitogen stimulation. The two strains differ in their maximum responsiveness, particularly when approaching confluence. The regulatory effects of cell density on the selective reduction of the high-affinity receptors for EGF and TGFjS have been reported. 44 The simultaneous stimulation by PDGF and EGF revealed that PDGF heightened the maximal response but did not alter the EC50 of EGF; thus, the additive effect of these factors was illustrated. The different responses to circulating growth factors seen in our study may occur at different sites in the biochemical pathway leading to DNA synthesis. They may be caused by alterations of growth factor receptors, a modulated regulation of transmembrane signaling (G-protein, phosphatidylinositol phosphodiesterase, tyrosine kinase), an abnormal release of intracellular messengers (inositol trisphosphate, calcium), a different sensitivity Of subsequent steps (diacylglycerol release, protein kinase C activation, tyrosine phosphorylation), or a modified synthesis of protooncogenes (c-fos, cmyc) believed to control the early steps to DNA synthesis. Indeed, many cellular defects in SHR and other models of essential hypertension have been described, namely, altered cell membrane ion transport, 45 -47 changed cyclic nucleotides 48 and adenylate cyclase system, 49 increased inositol trisphosphate 5051 and cytosolic Ca 2+ levels, 52 and higher calmodulin activity. 53 Genetic abnormalities of any of these steps may be, in turn, regulated by yet unknown genes. Our pilot study in fact indicates an altered expression of c-myc and c-fos in response to growth factors. 54 The present investigation has clearly demonstrated abnormalities of growth of cultured smooth muscle cells from SHR in response to growth factors. These abnormalities of growth suggest an abnormal balance between stimulatory and inhibitory control mechanisms. The genetic linkage of this phenomenon to the expression of hypertension and its pathogenetic and molecular mechanisms deserves further evaluation.
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